Abbott Laboratories

ABT
HealthcareDividend King
$104.00
1.96%Fair Value

Abbott Laboratories (ABT) is a Healthcare company that currently yields 1.96% — trading near fair value based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $89.40 and the overvaluation threshold at $134.62. Abbott Laboratories holds a quality score of 50/100 (Average), reflecting 54 consecutive years of dividend growth with a 93% payout ratio. The 5-year dividend CAGR stands at 12.7%.

ABT Dividend Yield History — Weiss Valuation

Underval. $89.40Overval. $134.62

Distance to undervalued

Waiting for a better entry

Needs about 14.0% downside to reach the Weiss buy zone

Undervaluation starts near $89.40, where the annual dividend would imply roughly 2.28% yield. That is 0.32% above today's yield.

Buy-zone price

$89.40

Target yield

2.28%

Research checklist

What to clear before buying the yield

Updated Nov 18, 2026

Dividend durability

54Y

Long dividend history supports a deeper look.

Earnings payout

93%

Coverage deserves a closer look in filings.

Cash payout

72%

Free cash flow coverage supports the payment.

Dividend growth

12.7%

Recent growth adds income compounding potential.

What changed

What changed since the last update

2026-11-17 → 2026-11-18

Price

-2.1%

$106.29 → $104.00

Price fell 2.1% since the prior snapshot.

Why Now?

Abbott Laboratories is trading at a fair valuation relative to its dividend history.

Current yield 2.0% vs historical max 3.4% (58% of maximum).

10 consecutive years without a dividend cut.

Elevated payout ratio of 93%.

What matters now

Read the signal before the headline yield

Valuation is neutral here: quality has to do more of the work than entry price.

The 50/100 quality score says the headline yield needs extra skepticism.

Start by checking whether payout coverage and business durability still support the dividend.

ABT Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$221

Year 10 Income

$902

Yield on Cost

9.6%

Total Income

$4,808

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Track actual vs. projected

See what ABT dividends you actually received with Sharesight

Dividend income log · Yield on cost · DRIP cost basis · Tax reports

→

More research

Full price history & technical analysis

TradingView ↗

Fundamentals, valuation & analyst ratings

FinViz ↗

Moat rating & analyst fair value

Morningstar ↗

Track dividends received & tax reports

Sharesight ↗

ABT Dividend Quality Score

Quality Score

50/ 100

Average

Payout Ratio0/25
Dividend Streak20/25
Growth (CAGR 5Y)20/20
Yield vs History5/15
FCF Coverage5/15

Key Metrics

Current Price$104.00
Annual Dividend$2.04
Current Yield1.96%
Yield — Max (10Y)3.36%
Yield — Min (10Y)1.55%
Undervalued Below$89.40
Overvalued Above$134.62
Payout Ratio92.54%
CAGR Dividend 5Y12.7%
CAGR Dividend 10Y13.8%
Years No Cut10y

Invest in ABT

Check Abbott Laboratories availability and current costs on eToro

Check eToro terms and availability →
Fractional sharesFees vary by countryCapital at risk

DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.

54
consecutive years of dividend growth